or Try an Advanced Search...

    Technical Analysis for KZR - Kezar Life Sciences, Inc.

    Grade Last Price % Change Price Change
    F 0.69 1.40% 0.01
    KZR closed up 1.4 percent on Friday, May 31, 2024, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: Jun 18
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical KZR trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 1.40%
    Lower Bollinger Band Walk Weakness 1.40%
    New 52 Week Low Weakness 1.40%
    Outside Day Range Expansion 1.40%
    Gapped Up Strength 1.40%
    Lower Bollinger Band Touch Weakness 1.40%
    Older End-of-Day Signals for KZR ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 2 days ago
    Possible Inside Day 2 days ago
    Lower Bollinger Band Support 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    Down 1% 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    KZR Chart by TradingView
    Basic chart:

    Profile

    Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Pharmaceutical Autoimmunity Molecule Therapeutics Immunity Enzon Pharmaceuticals

    Is KZR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 29 Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
    May 9 Kezar Life Sciences GAAP EPS of -$0.30
    May 9 Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
    May 6 Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    Apr 8 13 Best Penny Stocks to Buy According to Billionaire Ken Griffin
    Mar 27 From Pennies to Fortunes: 3 Stocks Set to Make Millionaires
    Mar 16 Diamonds in the Dust: 3 Penny Stocks Set to Soar 500% by 2026
    Mar 14 Kezar Life Sciences GAAP EPS of -$0.44
    Mar 14 Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
    Mar 8 Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
    See more KZR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.13
    52 Week Low 0.67
    Average Volume 724,430
    200-Day Moving Average 0.94
    50-Day Moving Average 0.81
    20-Day Moving Average 0.76
    10-Day Moving Average 0.73
    Average True Range 0.04
    RSI (14) 34.21
    ADX 33.03
    +DI 8.26
    -DI 26.34
    Chandelier Exit (Long, 3 ATRs) 0.74
    Chandelier Exit (Short, 3 ATRs) 0.80
    Upper Bollinger Bands 0.86
    Lower Bollinger Band 0.67
    Percent B (%b) 0.14
    BandWidth 25.84
    MACD Line -0.04
    MACD Signal Line -0.03
    MACD Histogram -0.0072
    Fundamentals Value
    Market Cap 50.52 Million
    Num Shares 72.8 Million
    EPS -1.21
    Price-to-Earnings (P/E) Ratio -0.57
    Price-to-Sales 9.91
    Price-to-Book 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.74
    Resistance 3 (R3) 0.73 0.72 0.73
    Resistance 2 (R2) 0.72 0.71 0.72 0.73
    Resistance 1 (R1) 0.71 0.70 0.70 0.71 0.73
    Pivot Point 0.69 0.69 0.68 0.69 0.69
    Support 1 (S1) 0.68 0.68 0.67 0.68 0.66
    Support 2 (S2) 0.66 0.67 0.66 0.66
    Support 3 (S3) 0.65 0.66 0.66
    Support 4 (S4) 0.65